Physician profile
Mark Wardenburg
NPI 1700870706
$2,699.13
in general payments reported to CMS, 2019-2025
15 companies · $235 in 2025
The $235 reported for 2025 was more than what 99% of Orthopedic (Chiropractor) providers received nationally (typical 2025 total: $40.35).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $469 · 2021: $534 · 2022: $688 · 2023: $215 · 2024: $227 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,295.16 | 2019-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $324.61 | 2020-2025 | General - Pain Management |
| Amgen INC. | $266.84 | 2024-2025 | Krystexxa, Repatha |
| Vertiflex, INC. | $185.83 | 2019 | |
| Spinal Simplicity, LLC | $180.71 | 2022 | |
| Nalu Medical, INC. | $144.88 | 2020 | |
| Stryker Corporation | $91.84 | 2021-2023 | Citrefix |
| Redhill Biopharma INC. | $46.41 | 2020 | |
| Merz Pharmaceuticals, LLC | $41.12 | 2024 | Xeomin |
| Zealand Pharma US, INC. | $32.32 | 2020 | |
| Abbvie INC. | $31.11 | 2023 | Botox |
| Depuy Synthes Sales INC. | $22.74 | 2021 | |
| Saxum Surgical, INC. | $17.65 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.28 | 2021 | |
| Forte Bio-Pharma LLC | $0.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wardenburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.